alexa Abstract | Effect of Docosahexaenoic Acid Supplementation on Glucose Tolerance and Markers of Inflammation in Overweight/Obese Pregnant Women: A Double-blind, Randomized, Controlled Trial
ISSN: 2376-127X

Journal of Pregnancy and Child Health
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

Background: Obese, pregnant women have exacerbated inflammation and insulin resistance that put them and their fetus at risk for adverse prenatal outcomes and future risk of cardiometabolic disease. Our objective was to determine the effects of 10 weeks of docosahexaenoic acid (DHA) supplementation on glucose tolerance and markers of inflammation in healthy, overweight/obese, pregnant women. Method: Using a randomized, double-blind, placebo-controlled trial, 60 women, with a pregravid body mass index ≥ 25 consumed placebo or DHA (800 mg DHA, algal oil) capsules for 10 weeks from 26 to 36 weeks gestation. Erythrocyte DHA (EDHA), plasma tumor necrosis factor (TNF-α), and interleukin 6 (IL-6) were measured at 36 weeks. Homeostatic model assessment of insulin resistance (HOMA-IR), beta cell function (HOMA-B %), and insulin sensitivity (HOMA-S %) were calculated from glucose and insulin measurements during a 2-hour meal challenge at 36 weeks. Data were analyzed using SPSS (version 22) and SAS (version 9.3). Results: After supplementation, the mean EDHA increased by 25% and decreased by 14% in the DHA or placebo group, respectively (P<0.0005). None of the markers of glucose metabolism were significantly different between treatment groups. There was a significant time by group interaction for TNF-α (P=0.03, η2=0.08) with DHA lessening the rise seen in TNF-α between 26 and 36 weeks gestation. Conclusion: DHA supplementation from 26 to 36 weeks of gestation improved the inflammatory environment of overweight/obese pregnant women. Glucose tolerance homeostasis was not significantly different between groups.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Debra A Krummel, Alison Baker Kuhn, Alison M Cassin, Sarah L Davis, Lindsay E Walker, Jane C Khoury and Theresa L Powell

Keywords

Docosahexaenoic acid (DHA), Pregnancy, Prenatal supplementation, Obesity, Inflammation, Glucose tolerance, Preclampsia in Pregnancy, Pregnancy Care, Pregnancy Constipation, Pregnancy Fitness, Pregnancy Nutrition, Smoking in Pregnancy, Stress in Pregnancy

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords